Tscan Therapeutics Inc
Biotechnology
Healthcare
TCRX
130 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.80
52 week high
6.00
high
1.87
52 week low
0.00
previous Close
1.78
P/E ratio
market cap
85.45 M
div yield
0
net profit margin
0.00 %
1571.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top